Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
Celebrating a 10 year partnership: ecancer and the IEO
Prof Gordon McVie - Editor in Chief, ecancer
Celebrating a 10 year partnership: ecancer and the IEO ( Prof Gordon McVie - Editor in Chief, ecancer )
19 Jul 2017
What’s important to patients in a non-curative setting?
Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK
What’s important to patients in a non-curative setting? ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )
14 Jul 2017
What to do when standard treatment fails?
Dr Christopher Fox - Nottingham University Hospitals, Nottingham, UK
What to do when standard treatment fails? ( Dr Christopher Fox - Nottingham University Hospitals, Nottingham, UK )
14 Jul 2017
How do we measure treatment success?
Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...
How do we measure treatment success? ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
14 Jul 2017
Novel models to personalise cancer therapeutics
Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden
Novel models to personalise cancer therapeutics ( Dr Olli Kallioniemi - Karolinska Institutet, Stockholm, Sweden )
4 Jul 2017
4 years of RESONATE data for CLL patients treated with ibrutinib
Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona...
4 years of RESONATE data for CLL patients treated with ibrutinib ( Dr Carolina Moreno Atanasio - Hospital de la Santa Creu i Sant Pau, Barcelona, Spain )
28 Jun 2017
Latest maintenance strategies in multiple myeloma
Prof Guillermo Ruiz-Arguelles and Prof McCarthy
Latest maintenance strategies in multiple myeloma ( Prof Guillermo Ruiz-Arguelles and Prof McCarthy )
25 Jun 2017
Front-line combinations in multiple myeloma: Highlights from EHA 2017
Prof Joy Ho and Prof Je-Jung Lee
Front-line combinations in multiple myeloma: Highlights from EHA 2017 ( Prof Joy Ho and Prof Je-Jung Lee )
25 Jun 2017
Latest in relapsed and refractory multiple myeloma
Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim
Latest in relapsed and refractory multiple myeloma ( Prof Heinz Ludwig, Prof Wee Joo Chng and Prof James Chim )
25 Jun 2017
Lenalidomide with CD19 antibodies in L-MIND
Dr Kami Maddocks - Ohio State University, Columbus, USA
Lenalidomide with CD19 antibodies in L-MIND ( Dr Kami Maddocks - Ohio State University, Columbus, USA )
25 Jun 2017
The Myeloma XI trial - lenalidomide or thalidomide in triplet
Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK
The Myeloma XI trial - lenalidomide or thalidomide in triplet ( Dr Charlotte Pawlyn - The Institute of Cancer Research, London, UK )
25 Jun 2017
Denosumab or zoledronic acid for bone disease in multiple myeloma
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab or zoledronic acid for bone disease in multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
25 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation